Skip to main content
PRISM BioLab Co.,LTD logo

PRISM BioLab Co.,LTD — Investor Relations & Filings

Ticker · 206A ISIN · JP3833190006 T Manufacturing
Open in API
Filings indexed 17 across all filing types
Latest filing 2024-06-14 Share Issue/Capital Cha…
Country JP Japan
Listing T 206A

About PRISM BioLab Co.,LTD

https://prismbiolab.com/ja/

PRISM BioLab is a biotechnology company specializing in drug discovery and development. It utilizes its proprietary PepMetics® technology platform to create orally available, small molecule drugs that target protein-protein interactions (PPIs), which are often considered 'undruggable'. The platform designs molecules that mimic key peptide structures, such as α-helices and β-turns, to modulate these interactions. The company's primary mission is to develop novel therapeutics for intractable diseases that currently lack effective treatments. PRISM BioLab advances its pipeline through both internal research programs and strategic collaborations with pharmaceutical partners.

Recent filings

Filing Released Lang Actions
訂正有価証券届出書（新規公開時）
Share Issue/Capital Change Classification · 98% confidence The document text contains Japanese regulatory headers such as "【提出書類】有価証券届出書" (Filing Document: Securities Registration Statement) and details related to a public offering ("募集") and secondary offering ("売出") of shares, including issuance amounts, book-building methods, underwriting agreements, and intended use of proceeds. This structure is characteristic of a prospectus or registration statement filed in Japan for an Initial Public Offering (IPO) or subsequent public offering of securities. In the context of US SEC filings, this is analogous to a Form S-1 or a registration statement related to a capital raise. Among the provided codes, 'CAP' (Capital/Financing Update) is the most appropriate category for a document detailing a public offering of stock, as it directly concerns fundraising and capital structure changes. The document is clearly the primary filing document itself, not just an announcement of a report (ruling 2 does not apply).
2024-06-14 Japanese
有価証券届出書（新規公開時）
Share Issue/Capital Change Classification · 98% confidence The document text contains Japanese headings such as "【提出書類】有価証券届出書" (Filing Document: Securities Registration Statement) and details regarding a public offering (募集) and secondary offering (売出) of shares, including expected amounts, book-building methods, underwriting agreements, and use of proceeds. This structure and content are characteristic of a Japanese securities filing related to an Initial Public Offering (IPO) or a subsequent public offering of shares. In the context of the provided definitions, a filing detailing the terms of a share issuance/offering aligns best with the 'Capital/Financing Update' (CAP) category, as it is a formal document detailing capital structure changes via issuance/offering. While it is a comprehensive filing, it is not the Annual Report (10-K) or an Interim Report (IR). Since it specifically details the terms of a share issuance/offering, CAP is the most precise fit over the general 'Regulatory Filing' (RNS).
2024-05-27 Japanese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.